OD2 LONG-ACTING RISPERIDONE IN SCHIZOPHRENIC PATIENTS COMPARED WITH ORAL OLANZAPINE AND HALOPERIDOL DECANOATE-A COST-EFFECTIVENESS ANALYSIS
Nov 1, 2002, 00:00
10.1016/S1098-3015(10)61224-7
https://www.valueinhealthjournal.com/article/S1098-3015(10)61224-7/fulltext
Title :
OD2 LONG-ACTING RISPERIDONE IN SCHIZOPHRENIC PATIENTS COMPARED WITH ORAL OLANZAPINE AND HALOPERIDOL DECANOATE-A COST-EFFECTIVENESS ANALYSIS
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(10)61224-7&doi=10.1016/S1098-3015(10)61224-7
First page :
Section Title :
Open access? :
No
Section Order :
32